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Background and study objective: Deep inspiration (DI) protects against methacholine-
induced bronchoconstriction in healthy subjects. We hypothesized that this bronchopro-
tective effect of DI depends upon the inspiratory flow rate.
Design: Prospective, controlled study.
Setting: Pulmonary function laboratory within a large tertiary medical center.
Participants: Ten healthy nonsmokers without asthma or rhinitis.
Measurements: First, we performed a methacholine challenge in the absence of DI to
determine the concentration sufficient to reduce FEV1 by 20%. On two subsequent days,
the challenge was repeated with the addition of either a fast or slow DI immediately
before the threshold concentration of methacholine. We calculated the % reduction in
FEV1 and FVC from baseline.
Results: Mean % reduction in FEV1 and FVC was significantly less with a fast DI than with no
DI (2073% vs. 3474% for FEV1, p ¼ 0.02; 1273% vs. 2373% for FVC, p ¼ 0.03); slow DIs
did not significantly affect the methacholine-induced reduction in lung function.
Conclusion: A fast DI is bronchoprotective while a slow DI is not. Elucidating the
conditions that maximize or alternatively, eliminate bronchoprotection in healthy subjects
may ultimately provide insight into the pathophysiology of asthma.
& 2007 Published by Elsevier Ltd.Published by Elsevier Ltd.
muscle; CT, threshold concentration of methacholine; DI, deep inspiration; FEV1, forced expiratory
; Mch, methacholine; RV, residual volume; SEM, standard error of the mean; TLC, total lung capacity.
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Deep inspiration (DI) offers an important defense against
bronchospasm in normal subjects. When a DI is taken after
inhalation of a direct spasmogen, such as methacholine
(Mch), the effect is bronchodilatory1–8 while a DI performed
before administration of a spasmogen leads to bronchopro-
tection7,9–12 from subsequent constriction. Asthmatic sub-
jects have a diminished bronchodilatory response to
DI3–5,8,11 and do not bronchoprotect.10,12 In fact, the lack
of DI-induced bronchoprotection is viewed as a major
cause of airway hyperresponsiveness.13 The mechanisms
of DI-induced bronchodilation and bronchoprotection and
how they are impaired in asthma remain elusive. Many
investigators have linked these phenomena to the ability of
a DI to stretch the airways.5,9,14–17 Subsequent studies
highlighted the important observation that although mild
asthmatics had an intact DI-induced stretch, unlike non-
asthmatics, they could not maintain the beneficial effect of
this stretch.18 Other studies demonstrated that varying
the velocity of stretch of DI influences the magnitude of
DI-induced bronchodilation.19,20 This is an important ob-
servation because it points towards smooth muscle or lung
mechanics as potential foci of interest in the quest to
understand the beneficial effects of DI. In this study, we
investigated the effect of the velocity of stretch on
DI-induced bronchoprotection in normal subjects by altering
inspiratory flow.
Methods
Subjects
Thirty-one healthy subjects were initially recruited for the
study by advertisement from the hospital community. They
reported no symptoms consistent with asthma or upper
airway disease and had never been diagnosed with asthma or
rhinitis by a physician. The subjects were screened by an
asthma symptom questionnaire, allergy skin testing and
routine Mch bronchoprovocation (the routine provocation
involves DIs). Twelve subjects were excluded based on the
screening results (nine had multiple positive allergy skin
tests, two had abnormal baseline spirometry and one had a
positive routine Mch challenge). Four subjects opted not toTable 1 Demographic characteristics of subjects.
Subject Sex Age (yr) FEV1
1 M 28 96
2 F 23 115
3 F 27 113
4 M 29 86
5 F 30 98
6 F 23 106
7 M 31 80
8 F 24 96
9 F 27 102
10 M 32 92
Mean7SEM 2771 9874continue in the study following screening. An additional five
subjects did not meet response and reproducibility criteria
(described in the ‘‘Protocol’’ section). The 10 subjects who
completed the study had normal baseline pulmonary
function [forced expiratory volume in 1 s (FEV1) and forced
vital capacity (FVC) % predicted: 9874% and 91710%,
respectively (mean7standard error of the mean (SEM)] and
were able to receive the highest dose of Mch (75mg/ml)
with p15% reduction in FEV1. They were life-long non-
smokers, had been free from upper respiratory infection for
at least 4 weeks and did not have caffeine on the testing
days. The demographic characteristics of these subjects are
outlined in Table 1. The study was approved by the
Institutional Review Board of the Mount Sinai School of
Medicine and informed, written consent was obtained from
each subject.Protocol
Following the above-described screening procedures, three
additional visits to the laboratory were required. Visits
were separated from each other by at least 2 days. On all 3
days, subjects received a modified Mch challenge.14
The protocol of the modified challenge included maximal
forced expiratory maneuvers at baseline and after the
final dose of Mch (this allowed for determination of FEV1
and FVC at the beginning and end of the challenge);
however, no DIs were permitted during the challenge and
only partial forced expirations were performed after each
incremental dose of Mch (baseline partial curves were also
obtained). In addition, Mch was inhaled with tidal inspira-
tions. The challenge endpoint was determined by a partial
FEV1/FVCp0.55, uncomfortable chest symptoms or by
reaching the highest dose level of Mch. The modified
challenge on Day 1 (Fig. 1A) was used to determine the
threshold concentration of Mch (CT) sufficient to produce a
X20% reduction in FEV1 from baseline. Only subjects
who met this criterion were studied further. On Days 2
and 3 (Fig. 1B), modified Mch challenge was conducted
identically except that immediately prior to CT, subjects
were instructed to either take a DI as rapidly as possible
to total lung capacity (TLC) (Day 2) or to inspire slowly to
TLC over 4–5 s (Day 3). The partial FEV1/FVC prior to CT
was required to be reproducible to within 10% on all 3 days(% pred) FVC (% pred) FEV1/FVC ratio
100 0.82
108 0.92
104 0.93
96 0.77
97 0.87
108 0.85
96 0.83
89 0.94
105 0.83
100 0.78
91710 0.8570.02
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Figure 1 Schematic diagram of the study protocol. (A) Day 1:
Modified Mch challenge with no DI prior to CT. (B) Days 2,3:
Modified Mch challenge with a fast (Day 2) or slow (Day 3) DI
prior to CT. The taller vertical line represents a single maximal
forced expiratory maneuver; the shorter vertical line represents
a single partial forced expiratory maneuver. Each time a
maneuver is performed, it is done in triplicate. Ci ¼ concentra-
tion of Mch inhaled by subject increasing by half log increments
(i ¼ 1, 2, etc.). y ¼ Successive concentrations of Mch, each
followed by three partial forced expiratory maneuvers.
CT ¼ threshold concentration of Mch as defined in ‘‘Methods’’
section.
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Figure 2 Mean percent reduction (7SEM) in FEV1 and FVC (see
‘‘Methods’’) on the three study days. Analysis of variance withLung function
Maximal and partial flow-volume curves were performed in
this study. For performance of maximal flow-volume curves,
subjects were told to inspire deeply to full inflation and,
without holding their breath, to exhale forcefully to residual
volume (RV). For partial flow–volume curves, they were
asked to breathe quietly and from end-tidal inspiration, to
exhale forcefully to RV. Each maneuver was done in
triplicate and the best FEV1 and FVC selected. Custom-
programmed spirometry software (adhering to American
Thoracic Society standards for maximal flow–volume
curves21) was used to display and evaluate the flow–volume
loops. Only curves with sharp peak flows were saved for
analysis. Data could also be displayed as volume vs. time and
flow vs. time with a feature that allowed for a digital read-
out of inspired volume and peak inspiratory flow.post hoc analysis revealed significant differences between fast
vs. slow DI (*) and between fast vs. no DI (y) for both FEV1 and
FVC (p ¼ 0.03).Data analysis
The percent reduction in FEV1 or FVC from baseline on all
study days was calculated as follows: [(Best baseline FEV1 or
FVCthe first FEV1 or FVC post-Mch)/best baseline FEV1 or
FVC] 100. The effect of a fast DI or slow DI on the percent
reduction in lung function (the ‘‘bronchoprotective’’ effect)
was evaluated by one-way, repeated measures analysis of
variance (ANOVA) with post hoc analysis by Fisher PLSD.22
Data are presented as mean7SEM. Statistical significance
was accepted for two-tailed p-valueso0.05.Results
Significant bronchoconstriction was induced during the
modified Mch challenge (Day 1, No DI). Subjects generally
complained of chest tightness and were frequently noted to
wheeze audibly. The percent reduction in FEV1 post-Mch
(compared to baseline) ranged from 20% to 60% (3474,
mean7SEM) and the percent reduction in FVC from 13% to
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Deep inspiration and flow rate 137947% (2373, mean7SEM). The average CT of Mch adminis-
tered to subjects to produce this effect was 40710mg/ml
(the range was 7.5–75mg/ml). Figure 2 demonstrates that
the mean percent reduction in FEV1 and in FVC was
significantly different on the 3 study days (ANOVA:
p ¼ 0.03 for both FEV1 and FVC). When a single fast DI was
taken prior to the CT of Mch, the percent reduction
(mean7SEM) in both FEV1 (2073) and FVC (1273) was
significantly less than in the challenge performed in the
absence of DI. In other words, there was a partial
‘‘bronchoprotective effect.’’ There was no significant
bronchoprotection attributable to a slow DI since the
percent reduction (mean7SEM) in FEV1 (3175) and FVC
(1974) from baseline was not statistically different from0
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Figure 3 Individual data comparing: (A) percent reduction in
FEV1 for no DI vs. a fast DI; (B) percent reduction in FEV1 for no
DI vs. a slow DI.that produced during the Mch challenge performed in the
absence of DI(p ¼ 0.62). Individual data for percent reduc-
tion in FEV1 showed that the majority of subjects (eight out
of the ten) demonstrated bronchoprotection with a fast DI
(Fig. 3A). As shown in Fig. 3B, only half of the subjects
bronchoprotected with a slow DI, while half bronchocon-
stricted further. No subjects demonstrated bronchoprotec-
tion by a slow DI without bronchoprotection by the fast DI.
Individual data of the percent reduction in FEV1 and FVC
from baseline induced by a fast vs. slow DI are illustrated in
Figs. 4A and B, respectively. The fast DI was clearly
superior for achieving bronchoprotection for the majority
of individuals (9 out of 10 based on FEV1 and 8 out of 10 for
FVC).0
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Figure 4 Individual data comparing: (A) percent reduction in
FEV1 for a slow DI vs. a fast DI; (B) percent reduction in FVC for a
slow DI vs. a fast DI.
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slow DI were due to differences in the inspired volume (from
the beginning to the end of the deep inspiration), we
compared this parameter and found no significant difference
between the inspired volume during the fast DIs compared
to the slow DIs (mean7SEM, 3.0270.11 l vs. 3.2370.20 l,
p ¼ 0.17). In contrast, the maximal inspiratory flow for the
fast DIs was approximately five times faster than that for the
slow DIs (mean7SEM, 5.5870.46 vs. 1.1570.08 l/s,
p ¼ 0.0001).Discussion
Numerous investigators have described bronchodilation
following DI in healthy subjects pre-constricted with
Mch,1–8 but it is more recently that a distinct bronchopro-
tective effect of a DI initiated before Mch has been observed
and linked to airway health.7,9–12 The work of Scichilone and
colleagues indicates that individuals with airway hyperre-
sponsiveness (including rhinitis) lack DI-induced broncho-
protection while they retain some ability to bronchodilate.
These results suggest that loss of DI-induced bronchoprotec-
tion may constitute an earlier alteration in lung function
(perhaps preceding the development of asthma) and
that the mechanisms governing the two phenomena
(bronchodilation vs. bronchoprotection) may be different.
In this study, we have confirmed that, in healthy subjects,
even a single DI has a bronchoprotective effect against the
airway smooth muscle (ASM) constrictor, Mch. In addition,
we have demonstrated for the first time that the bronch-
oprotective effect of a DI is dependent on inspiratory flow.
Our results show that a fast DI is bronchoprotective while a
slow DI is not.
Malmberg et al.9 was the first to describe DI-induced
bronchoprotection in humans by observing that the initial
maximal spirogram in a series affected the magnitude of
forced expiratory flow on the subsequent maneuver. Kapsali
and colleagues10 showed that this bronchoprotective effect
was dose dependent in healthy subjects since five DIs prior
to a single dose of Mch reduced constriction more than two
DIs. Supportive evidence from animal studies comes from
evaluation of the effect of tissue stretch on muscle force.
Several in vitro investigations have shown that stretching or
changing the length of relaxed ASM results in an initial
decrease in isometric tension.23–26
To our knowledge, there are no human studies other than
our own on the effect of the rate of DI on the magnitude of
the induced bronchoprotection. Wang and colleagues23 did
investigate the role of frequency of a single stretch on force
generation in resting porcine tracheal smooth muscle. This
group documented that a quicker stretch results in slightly
greater reduction in force than a slower stretch. Of note,
the rate of DI seems to have a similar effect on DI-induced
bronchodilation, since following induced constriction, fast
inspirations reduced airway resistance more than slow
inspirations in both normal20 and asthmatic19 subjects. In
an in vitro study by Shen and colleagues,27 there was
a similar correlation between the frequency of length
oscillations applied to activated canine tracheal smooth
muscle and force decrement. The mechanism of DI-induced
bronchoprotection is not known. ASM plasticity, or theability of the muscle to adapt to length changes by
reorganizing its contractile apparatus,17,23,24,27–29 provides
one explanation for the phenomenon. Neurohumoral me-
chanisms may also be involved.30–35
In the current study, a fast or slow DI was performed
immediately before the final dose of Mch administered in a
modified challenge (no DIs following baseline lung function)
and reproducibility of the lung function just prior to the DI
was carefully monitored and confirmed. Since the ASM
should already have been somewhat stiff due to the
conditions of the protocol,14–17,36,37 plastic rearrangement
of the cytoskeleton could not be the sole operative
mechanism. Fredberg et al.16,38 have postulated that in
activated muscle, the strain produced by DI leads
to detachment of myosin heads from actin filaments,
decreasing the number of cross-bridges and thus decreasing
active force. It seems logical that the stretch imposed
by a fast DI would increase mechanical strain and break
more cross-bridges than the stretch associated with a slow
DI. A fast DI is associated with a greater elastic recoil
pressure than a slow DI.39–41 The tension within ASM is
dependent upon the transpulmonary pressure as well as the
radius of curvature of the airway and it is the muscle tension
that determines the degree of cross-bridge disruption.
Thus a fast DI, with greater ASM tension, would be expected
to break more cross-bridges than a slow DI and to have a
greater effect on increasing airway caliber. The stretch
of a slow DI may have allowed the muscle to lengthen
without disrupting cross-bridges, thus adapting to the length
change so as to maintain higher forces. Gunst and Tang29
suggest an alternative explanation for the effect of rate of
stretch on cross-bridge dynamics. They propose that if the
rate of the imposed stretch is faster than the active
shortening velocity of the muscle, then less reattachment
of detached cross-bridges will occur and muscle force will
remain low. Presumably, if ASM were sufficiently stiff, as
may be the case in asthma,5,15,16,42,43 then the stretch
imposed by a DI should be ineffective in achieving
bronchoprotection regardless of the inspiratory flow. This
has been demonstrated by Kapsali et al.10 and Scichilone
et al.12 and we have unpublished observations supporting
the same notion.
We controlled for inspiratory volume in this study
since the size of a DI influences pulmonary function.44
The inspiratory flow was standardized to ensure that
the fast DI had a significantly greater inspiratory flow than
the slow DI. Although we also attempted to control
expiratory flow following the two maneuvers in the study,
this was more difficult since subjects tended to exhale
more rapidly following a fast DI than they did after a
slow DI (p ¼ 0.02). It seems unlikely that the results seen in
this study were due to differences in expiratory flow,
however. Earlier investigations have established that DIs
have greater effects on pulmonary function than do deep
expirations.20,45
There are potential confounding aspects of our metho-
dology that deserve mention. We chose maximal expiratory
maneuvers to assess the degree of bronchoconstriction.
These maneuvers are preceded by a DI, which can itself alter
airway caliber. While it may have been purer to use partial
forced expiratory flows or resistance measurements, we felt
that the maximal maneuvers were more reliable and
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changes in total lung capacity by airway tone suggest that
analysis of partial forced expiratory flows at isovolume may
not be the most valid analytical approach. Most importantly,
the DI incorporated into the maximal maneuver preceded
every spirometric outcome we considered so that any
potential bronchodilatory effect was introduced in all three
arms of the study. In fact, analysis of the three successive
maximal expiratory maneuvers performed post-Mch sup-
ports the presence of DI-induced bronchodilation since the
third post-Mch FEV1 was 10–20% higher than the first on all 3
study days (data not shown). In unpublished data from 9
asthmatics who participated in an identical protocol, we
found a similar degree of bronchodilation based on the three
trials of post-Mch spirometry in all arms of the study (no DI,
slow DI, fast DI before the CT of methacholine) without any
difference between the arms based on the first post-Mch
trial. The lack of a difference in the 1st post-Mch spirometry
in asthmatics therefore suggests a defect in bronchoprotec-
tion by DI. By inference, we can confidently argue that the
differences in the arms of the protocol detected by the first
post-Mch spirometry in healthy individuals, reflect differ-
ences in DI-induced bronchoprotection and not bronchodila-
tion. Another potential confounder is that the differential
effects of a fast compared to a slow DI on cross-bridge
breakage may have altered the site of Mch deposition and
thus influenced the degree of bronchoprotection. However,
in the study of Kapsali et al.,10 radiolabeled technetium was
inhaled as an aerosol in the absence of and after five DIs and
there was no evidence of differential deposition of the
aerosol in the lungs.
In conclusion, the current study confirms the broncho-
protective effect of a single DI in healthy subjects and
demonstrates that this effect is clearly dependent upon
inspiratory flow. A fast DI is bronchoprotective while a slow
DI is not. Elucidating the conditions that maximize or
alternatively, eliminate bronchoprotection in healthy sub-
jects may ultimately provide insight into the pathophysiol-
ogy of the asthmatic state.
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